Abbreviations
H2S: hydrogen sulfide, COX: Cytochrome c oxidase, CBS: Cystathionine-β-synthase, CSE: Cystathionine-γ-lyase, CO: carbon monoxids, IRI: ischemia-reperfusion injury, CAT: cysteine aminotransferase, 3-MP: 3-mercaptopyruvic acid, DAO: D-amino acid oxidase, SQQR: sulfoquinone oxidoreductase, GSH: glutathione, GSSH: glutathione disulfide, TSMT: Thiol-S-methyltransferas, LR: Lawesson reagent, GYY4137: morpholin-4-ium 4 methoxyphenyl (morpholino) phosphinodithioate, DAS: diallyl sulfides, DADS: diallyl disulfides, DATS: diallyl trisulfides, MSN: mesoporous silica nanoparticles, AP39: 10-oxo-10-(4-(3-thioxo-3H-1,2-dithiol-5yl)phenoxy)decyl, PKC: protein kinase C, ETC: electron transfer chain, XOD: xanthine oxidase system, ROS: reactive oxygen species, NOS: nitric oxide synthase, XDH: xanthine dehydrogenase, HIF-1α: hypoxia inhibitory factor-1α , PLA2: phospholipase A2, APAF-1: apoptosis protease activating factor 1, TRADD: TNFR related death domain, MLKL: mixed lineage kinase like domain, RARP: poly(ADP-ribose)polymerase, SOD: superoxide dismutase, Nrf2: factor-E2-related factor-2, MCP-1: chemotactic protein-1, NMDA: N-methyl-D-aspartate receptor, AKI: acute kidney injury, GFR: glomerular filtration rate, HIR: hepatic ischemia-reperfusion, DR: diabetic retinopathy, RAO: retinal artery occlusion.